Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Monit Comput ; 24(1): 35-9, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19915950

RESUMO

OBJECTIVE: Serious accidents during hemodialysis such as a large amount of blood loss are often caused by venous needle dislodgement. To develop a bleeding sensor based on a photo sensor for monitoring the needle sites, we studied effects of liquids and porcine blood on light transmission through a thin gauze pad with a basic photo sensor. METHODS: The photo sensor consisted of an ordinary electrical circuit, a light emitting diode (LED, lambda max = 645 nm), a photo diode (PD), and a thin gauze pad placed between the LED and PD that were tightly attached to the edges of a plastic clip. The light transmitted through the gauze pad, soaked with liquids or porcine blood dropped on it, was measured with a digital voltmeter. The liquids were reverse osmosis water, physiological saline, glucose in water at 5, 10, 20, 40 and 50%, porcine plasma, and porcine blood (Hct 40, 30 and 20%). RESULTS: The liquids on a tight-weave gauze pad, significantly increased the voltage (light transmission) from 0.412 +/- 0.003 V (SD) to 0.794 +/- 0.025 V (minimum, by reverse osmosis water) and to 0.945 +/- 0.011 V (maximum, by 50% glucose). The porcine blood significantly decreased the voltage from 0.412 to 0.195 +/- 0.030 V in Hct 40%, to 0.334 +/- 0.035 in Hct 30%, to 0.397 +/- 0.007 V in Hct 20%. The higher the concentration of glucose, the more the light transmission increased. The higher concentration of Hct, the more the light transmission decreased. Similar results were also shown for the loose-weave pad. CONCLUSIONS: Using two types of gauze pads, we confirmed that liquids significantly increased light transmission through gauze pad, but porcine blood decreased light transmission. This opposite response can be used to distinguish liquids from blood on a gauze pad.


Assuntos
Cateterismo Periférico/efeitos adversos , Hemorragia/diagnóstico , Hemorragia/etiologia , Monitorização Fisiológica/métodos , Diálise Renal/efeitos adversos , Seringas/efeitos adversos , Animais , Bandagens , Engenharia Biomédica , Biologia Computacional , Humanos , Técnicas In Vitro , Luz , Modelos Animais , Monitorização Fisiológica/instrumentação , Suínos
2.
Biomed Res ; 29(1): 27-32, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18344595

RESUMO

Although it is known that tea catechins exert potent effects in obese subjects, there is scant information concerning these effects on body weight gain and body fat accumulation in the non-obese. We studied normal rats fed a normal diet and water containing either 0.1% or 0.5% tea catechins to examine the effects on body fat content and serum cholesterol levels, as well as evaluating whether the effect is related to bile acids, which in recent years have emerged as an inducer of energy expenditure. The administration of 0.5% catechins decreased the accumulation of body fat and the serum levels of cholesterol and bile acids. These results indicate that tea catechins modulate lipid metabolism not only in obese subjects, but also in the non-obese.


Assuntos
Tecido Adiposo/efeitos dos fármacos , Catequina/farmacologia , Dieta , Chá , Adiposidade/efeitos dos fármacos , Animais , Fármacos Antiobesidade/farmacologia , Ácidos e Sais Biliares/sangue , Peso Corporal/efeitos dos fármacos , Colesterol/sangue , Metabolismo Energético/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar
3.
J Cardiovasc Pharmacol ; 44(6): 639-44, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15550781

RESUMO

OBJECTIVES: Although we have previously shown that mexiletine might protect myocardium during acute ischemia, the precise mechanism was unclear. In the present study, the mechanism of this effect was examined by using selective K-ATP channel blockers in closed-chest acute ischemia model in rabbits. METHODS: In 40 rabbits, the large left ventricular branch (LLVB) of the left coronary artery was occluded for 30 minutes by inserting a catheter bead (varphi0.5-0.7 x 1.5 mm) through the left carotid artery and was then reperfused. The rabbits were divided into the following 5 groups: (1) control group (n = 8); (2) mexiletine (Mex) group (n = 8, continuous infusion of Mex 24 mg/kg/h); (3) Mex + 5-hydroxydecanoate (5HD) group (n = 8, preadministration of 5HD, 5 mg/kg, followed by Mex infusion); (4) Mex + HMR1098 (selective sarcolemmal K-ATP channel blocker) group (n = 8, preadministration of HMR1098, 3 mg/kg, followed by Mex infusion); and (5) pilsicainide (Pil) group (n = 8, continuous infusion of Pil 18 mg/kg/h). The incidence of ventricular arrhythmia, hemodynamics, left ventricular ejection fraction (LVEF), and infarction size were evaluated and compared among the 5 groups. RESULTS: The incidence of ventricular arrhythmia was lower in groups treated with Mex than the control. The hemodynamics did not show significant differences among the 5 groups. Although the LVEF at 30 minutes after reperfusion was lower in the Mex group (41 +/- 3%, P < 0.001) than the control group (48 +/- 3%), the LVEF at 360 minutes after reperfusion had recovered and became higher in the Mex group (62 +/- 3%, P < 0.001) than the control group (55 +/- 3%). The infarction size was smaller in the Mex group (30 +/- 5%, P = 0.028) than the control group (51 +/- 8%). These effects of Mex were negated by HMR1098 but not by 5HD and were larger than the effects of Pil. CONCLUSIONS: Mex showed improvement in the LVEF in the later phase after reperfusion as well as a reduction in ventricular arrhythmia. The cardioprotective effect of Mex was considered to appear through its action on the sarcolemmal K-ATP channel.


Assuntos
Antiarrítmicos/uso terapêutico , Lidocaína/análogos & derivados , Mexiletina/uso terapêutico , Isquemia Miocárdica/tratamento farmacológico , Isquemia Miocárdica/patologia , Miocárdio/patologia , Canais de Potássio/efeitos dos fármacos , Sarcolema/metabolismo , Transportadores de Cassetes de Ligação de ATP , Doença Aguda , Animais , Modelos Animais de Doenças , Eletrocardiografia/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Canais KATP , Lidocaína/farmacologia , Infarto do Miocárdio/patologia , Traumatismo por Reperfusão Miocárdica/tratamento farmacológico , Traumatismo por Reperfusão Miocárdica/patologia , Canais de Potássio/agonistas , Canais de Potássio Corretores do Fluxo de Internalização , Coelhos , Sarcolema/efeitos dos fármacos , Bloqueadores dos Canais de Sódio/farmacologia , Volume Sistólico/efeitos dos fármacos , Função Ventricular Esquerda/efeitos dos fármacos
4.
Circ J ; 66(4): 403-10, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11954958

RESUMO

ATP-sensitive K+ (KATP) channel openers have a cardioprotective effect and so mexiletine (Mex), a class Ib anti-arrhythmic drug, may also be cardioprotective because of its KATP channel-opening effect. The present study examined the effect of Mex on acute myocardial ischemia in a closed-chest acute ischemia and reperfusion model in rabbits. The rabbits were divided into 3 groups: (1) control (n=8); (2) Mex (n=8), continuous infusion of mexiletine (24 mg x kg(-1) h(-1)); and (3) Mex+Gli (n=8), pre-administration of glibenclamide (Gli; 0.5mg/kg) followed by mexiletine infusion. The incidence of arrhythmia, the hemodynamics and left ventricular ejection fraction (LVEF), and the infarct size were evaluated and compared among the 3 groups. The incidence of fatal ventricular fibrillation (VF) was least in the Mex group. The LVEF at 30 min after reperfusion was least in the Mex group, but at 360 min after reperfusion, it was least in the Mex+Gli group. The area of myocardial infarction determined by 2,3-triphenyltetrazolium chloride (TTC) staining was smallest in the Mex group. In this model, Mex reduced infarct size and improved left ventricular function during the late phase after reperfusion, although the effect was totally negated by the addition of glibenclamide.


Assuntos
Antiarrítmicos/uso terapêutico , Cardiotônicos/uso terapêutico , Proteínas de Membrana/fisiologia , Mexiletina/uso terapêutico , Isquemia Miocárdica/prevenção & controle , Doença Aguda , Animais , Angiografia Coronária , Vasos Coronários/efeitos dos fármacos , Vasos Coronários/fisiopatologia , Modelos Animais de Doenças , Ativação do Canal Iônico/efeitos dos fármacos , Proteínas de Membrana/efeitos dos fármacos , Isquemia Miocárdica/diagnóstico por imagem , Isquemia Miocárdica/fisiopatologia , Canais de Potássio , Coelhos , Fatores de Tempo , Função Ventricular Esquerda/efeitos dos fármacos , Função Ventricular Esquerda/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...